Open access
Oct 2026
Five‐Year Survival Analyses on Non‐Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Regimens Plus Surgery: A Propensity Score Matching, Real‐World Cohort Study
Non‐pathological complete response (non‐pCR) is common in esophageal squamous cell carcinoma (ESCC) patients after neoadjuvant therapy, yet evidence guiding long‐term outcomes and postoperative risk stratification in the immunotherapy era remains limited.
Wei-Bin Liu, Yu-Jie Deng, Yang-Chih Lin et al.
· Cancer Medicine · 0 citations